Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × NSCLC × Liquid Biopsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplastic Cells, Circulating 4 Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Salivary Gland Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Mouth Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hematopoietic and Lymphoid System Neoplasm 1 Head and Neck Neoplasms 1 Glioma 1 Disease 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colonic Neoplasms 1 Carcinoma, Lobular 1

Interventions

osimertinib 10 Pemetrexed 10 Carboplatin 10 aflutinib 8 Drug Therapy 7 Radiotherapy 6 Gefitinib 6 anlotinib 5 Docetaxel 5 Cisplatin 5 Vinorelbine 4 Radiosurgery 4 Paclitaxel 4 Gemcitabine 4 tislelizumab 3 pembrolizumab 3 icotinib 3 apatinib 3 HM781-36B 3 Erlotinib Hydrochloride 3 toripalimab 2 spartalizumab 2 Tyrosine Kinase Inhibitors 2 Thalidomide 2 Surgical Procedures, Operative 2 S 1 (combination) 2 Platinum 2 Immune Checkpoint Inhibitors 2 HMPL-013 2 Chemotherapy, Adjuvant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02890849 2024-02-23

RadImm01

Xinqiao Hospital of Chongqing

Phase NA Completed

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡